Skip to content
Already, 2023 is looking like a dynamic year for biotech on the state level as state legislatures nationwide get ready to tackle a few […]
4 things for biotech to watch in the 2023 state legislatures Read More »
The 2022 midterms are officially behind us – so, what happened, and what does biotech need to know going into the new year? We
2022 midterms recap: what happened and what the results mean for biotech Read More »
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk of maternal mortality, to
How Dobbs v. Jackson is affecting vaccine innovation Read More »
Illinois Governor J.B. Pritzker has announced $5 million in state-funded grants for businesses that have received federal funding through the Small Business Innovation Research
Illinois announces $5 million grant-match program to boost innovation Read More »
Paying for healthcare in the United States has been a challenging and controversial issue for years. In a landscape managed by private insurers, Medicaid,
To ensure access for all, healthcare payment models need innovation Read More »
While midterms results are still being tallied, we know a few key election results—and these results can give us some early insight into the
What we know (so far) the day after the midterms Read More »
The midterms are here. And while the days of knowing key race results the evening of Election Day seem to be long gone, it’s
2022 Midterms Preview: 4 things to watch on Election Day Read More »
At the Pantheon Awards 2022 event on Thursday, California Life Sciences (CLS) honored three Biotechnology Innovation Organization (BIO) leaders and member companies. CLS is
California Life Sciences recognizes BIO leaders and member companies Read More »
The Inflation Reduction Act (IRA), signed into law on August 16, offered historic investments in energy security and climate change. However, the legislation also
AZBio President: IRA could have ‘long-term, unintended consequences’ Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
